Latest filing intelligence

ABBOTT LABORATORIES (ABT)

Read the latest ABT filing as a structured brief: high-signal changes, financial snapshot, and direct links back to the official SEC source.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

ABBOTT LABORATORIES latest filing summary

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for ABT shows revenue was $44.3B and net income was $6.5B.

Key changes

What stands out in the latest report

  • Revenue moved to $44.3B from $42.0B (+5.7% vs prior).
  • Net income moved to $6.5B from $13.4B (-51.3% vs prior).
  • Diluted EPS moved to $3.72 from $7.64 (-51.3% vs prior).

Current read

Mixed read

Financial snapshot

Latest reported figures

Revenue $44.3B
Net income $6.5B
EPS $3.72
Operating cash flow $9.6B

Trend section

Recent revenue trend

Q3 $10.6B

Period ended 2024-09-30

Q1 $10.4B

Period ended 2025-03-31

Q2 $11.1B

Period ended 2025-06-30

Q3 $11.4B

Period ended 2025-09-30

Trend section

Recent EPS trend

Q3 N/A

Filed period trend snapshot.

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking